Myeloperoxidase up-regulates the catalytic activity of inducible nitric oxide synthase by preventing nitric oxide feedback inhibition.
Kinetic and structure analysis of inducible nitric oxide synthase (iNOS) revealed that, in addition to the increase of iNOS expression in inflamed areas, the major pathway causing overproduction of NO is destabilization of the iNOS-nitrosyl complex(es) that form during steady-state catalysis. Formation of such a complex allows iNOS to operate at only a fraction (20-30%) of its maximum activity. Thus, bioavailability of NO scavengers at sites of inflammation may play an essential role in up-regulation of the catalytic activity of iNOS, by preventing the catalytic activity inhibition that is attributed to nitrosyl complex formation. Myeloperoxidase (MPO), a major NO scavenger, is a pivotal enzyme involved in leukocyte-mediated host defenses. It is thought to play a pathogenic role under circumstances such as acute inflammatory tissue injury and chronic inflammatory conditions. However, a detailed understanding of the interrelationship between iNOS and MPO at sites of inflammation is lacking. We used direct spectroscopic, HPLC, and selective NO-electrode measurements to determine the interdependent relationship that exists between iNOS and MPO and the role of the MPO/H2O2 system in up-regulating the catalytic activity of iNOS that occurs at sites of inflammation. Scavenging free NO from the iNOS milieu by the MPO/H2O2 system subsequently restores the full capacity of iNOS to convert L-arginine to product (NO), as judged by the increase in the rates of citrulline and nitrite/nitrate production. Studies of iNOS catalytic mechanisms and function are essential to a more fundamental understanding of these factors, which govern iNOS-dependent processes in human health and disease.
Galijasevic
Semira
S
Department of Obstetrics and Gynecology, C. S. Mott Center for Human Growth and Development, Wayne State University, Detroit, MI 48201, USA.
Saed
Ghassan M
GM
Diamond
Michael P
MP
Abu-Soud
Husam M
HM
D000818:Animals; D001120:Arginine / Q000737:chemistry; D002384:Catalysis; D002851:Chromatography, High Pressure Liquid; D002956:Citrulline / Q000737:chemistry; D004563:Electrochemistry; D004926:Escherichia coli / Q000378:metabolism; D025461:Feedback, Physiological; D006861:Hydrogen Peroxide / Q000737:chemistry; D007249:Inflammation; D007700:Kinetics; D051379:Mice; D008892:Milk / Q000378:metabolism; D008954:Models, Biological; D008956:Models, Chemical; D009566:Nitrates / Q000737:chemistry; D009569:Nitric Oxide / Q000378:metabolism*; D019001:Nitric Oxide Synthase / Q000737:chemistry*; D052247:Nitric Oxide Synthase Type II; D009573:Nitrites / Q000737:chemistry; D010100:Oxygen / Q000378:metabolism; D009195:Peroxidase / Q000502:physiology*; D011485:Protein Binding; D012333:RNA, Messenger / Q000378:metabolism; D013053:Spectrophotometry; D013997:Time Factors; D014466:Ultraviolet Rays; D015854:Up-Regulation
D009566:Nitrates; D009573:Nitrites; D012333:RNA, Messenger; D002956:Citrulline; D009569:Nitric Oxide; D001120:Arginine; D006861:Hydrogen Peroxide; D009195:Peroxidase; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; C496317:Nos2 protein, mouse; D010100:Oxygen